207 related articles for article (PubMed ID: 33067920)
21. Glomerular Immunodeposits of Patients with IgA Nephropathy Are Enriched for IgG Autoantibodies Specific for Galactose-Deficient IgA1.
Rizk DV; Saha MK; Hall S; Novak L; Brown R; Huang ZQ; Fatima H; Julian BA; Novak J
J Am Soc Nephrol; 2019 Oct; 30(10):2017-2026. PubMed ID: 31444275
[TBL] [Abstract][Full Text] [Related]
22. Increased immunoglobulin-secreting cells in the blood of patients with active idiopathic IgA nephropathy.
Schena FP; Mastrolitti G; Fracasso AR; Pastore A; Ladisa N
Clin Nephrol; 1986 Oct; 26(4):163-8. PubMed ID: 3536230
[TBL] [Abstract][Full Text] [Related]
23. Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits complicated by immunoglobulin A nephropathy in the renal allograft.
Sawada A; Kawanishi K; Horita S; Koike J; Honda K; Ochi A; Komoda M; Tanaka Y; Unagami K; Okumi M; Shimizu T; Ishida H; Tanabe K; Nagashima Y; Nitta K
Nephrology (Carlton); 2016 Jul; 21 Suppl 1():48-52. PubMed ID: 26971743
[TBL] [Abstract][Full Text] [Related]
24. Crucial Role of AIM/CD5L in the Development of Glomerular Inflammation in IgA Nephropathy.
Takahata A; Arai S; Hiramoto E; Kitada K; Kato R; Makita Y; Suzuki H; Nakata J; Araki K; Miyazaki T; Suzuki Y
J Am Soc Nephrol; 2020 Sep; 31(9):2013-2024. PubMed ID: 32611589
[TBL] [Abstract][Full Text] [Related]
25. Characterization of T-Cell receptor repertoire in immunoglobulin a nephropathy.
Ho SY; Kao CC; Chang CM; Chou YC; Luo WT; Chou WH; Tsai IL; Wu MS; Chang WC
Biomark Res; 2024 Feb; 12(1):23. PubMed ID: 38342914
[TBL] [Abstract][Full Text] [Related]
26. Experimental murine IgA nephropathy following passive administration of vomitoxin-induced IgA monoclonal antibodies.
Yan D; Rumbeiha WK; Pestka JJ
Food Chem Toxicol; 1998 Dec; 36(12):1095-106. PubMed ID: 9862652
[TBL] [Abstract][Full Text] [Related]
27. Systemic and mucosal IgA responses to systemic antigen challenge in IgA nephropathy.
Layward L; Finnemore AM; Allen AC; Harper SJ; Feehally J
Clin Immunol Immunopathol; 1993 Dec; 69(3):306-13. PubMed ID: 8242901
[TBL] [Abstract][Full Text] [Related]
28. Characteristics Peripheral Blood IgG and IgM Heavy Chain Complementarity Determining Region 3 Repertoire before and after Immunization with Recombinant HBV Vaccine.
Ma L; Wang X; Bi X; Yang J; Shi B; He X; Ma R; Ma Q; Yao X
PLoS One; 2017; 12(1):e0170479. PubMed ID: 28114326
[TBL] [Abstract][Full Text] [Related]
29. Dendritic cells of IgA nephropathy patients have an impaired capacity to induce IgA production in naïve B cells.
Eijgenraam JW; Woltman AM; Kamerling SW; Briere F; de Fijter JW; Daha MR; van Kooten C
Kidney Int; 2005 Oct; 68(4):1604-12. PubMed ID: 16164637
[TBL] [Abstract][Full Text] [Related]
30. Abnormalities of the IgA immune system in members of unrelated pedigrees from patients with IgA nephropathy.
Schena FP; Scivittaro V; Ranieri E; Sinico R; Benuzzi S; Di Cillo M; Aventaggiato L
Clin Exp Immunol; 1993 Apr; 92(1):139-44. PubMed ID: 8467558
[TBL] [Abstract][Full Text] [Related]
31. Profiling of autoantibodies in IgA nephropathy, an integrative antibiomics approach.
Sigdel TK; Woo SH; Dai H; Khatri P; Li L; Myers B; Sarwal MM; Lafayette RA
Clin J Am Soc Nephrol; 2011 Dec; 6(12):2775-84. PubMed ID: 22157707
[TBL] [Abstract][Full Text] [Related]
32. Dietary zinc is a key environmental modifier in the progression of IgA nephropathy.
Maiguma M; Suzuki Y; Suzuki H; Okazaki K; Aizawa M; Muto M; Tomino Y
PLoS One; 2014; 9(2):e90558. PubMed ID: 24587392
[TBL] [Abstract][Full Text] [Related]
33. Expression of the mucosal gamma delta T cell receptor V region repertoire in patients with IgA nephropathy.
Olive C; Allen AC; Harper SJ; Wicks AC; Feehally J; Falk MC
Kidney Int; 1997 Oct; 52(4):1047-53. PubMed ID: 9328944
[TBL] [Abstract][Full Text] [Related]
34. Immunostaining for galactose-deficient immunoglobulin A is not specific for primary immunoglobulin A nephropathy.
Cassol CA; Bott C; Nadasdy GM; Alberton V; Malvar A; Nagaraja HN; Nadasdy T; Rovin BH; Satoskar AA
Nephrol Dial Transplant; 2020 Dec; 35(12):2123-2129. PubMed ID: 31369128
[TBL] [Abstract][Full Text] [Related]
35. Clinical significance of IgG deposition in the glomerular mesangial area in patients with IgA nephropathy.
Wada Y; Ogata H; Takeshige Y; Takeshima A; Yoshida N; Yamamoto M; Ito H; Kinugasa E
Clin Exp Nephrol; 2013 Feb; 17(1):73-82. PubMed ID: 22752397
[TBL] [Abstract][Full Text] [Related]
36. Phosphatidylethanolamine binding protein-4 (PEBP4) is increased in IgA nephropathy and is associated with IgA-positive B-cells in affected kidneys.
Taylor S; Pieri K; Nanni P; Tica J; Barratt J; Didangelos A
J Autoimmun; 2019 Dec; 105():102309. PubMed ID: 31402200
[TBL] [Abstract][Full Text] [Related]
37. Similarity measurements of B cell receptor repertoire in baseline mice showed spectrum convergence of IgM.
Wu H; Zhou Z; Xie S; Yan R; Gong M; Tian X; Wang Z
BMC Immunol; 2022 Mar; 23(1):11. PubMed ID: 35246036
[TBL] [Abstract][Full Text] [Related]
38. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases.
Tissandié E; Morelle W; Berthelot L; Vrtovsnik F; Daugas E; Walker F; Lebrec D; Trawalé JM; Francoz C; Durand F; Moura IC; Paradis V; Moreau R; Monteiro RC
Kidney Int; 2011 Dec; 80(12):1352-63. PubMed ID: 21866091
[TBL] [Abstract][Full Text] [Related]
39. Self-aggregated deglycosylated IgA1 with or without IgG were associated with the development of IgA nephropathy.
Yan Y; Xu LX; Zhang JJ; Zhang Y; Zhao MH
Clin Exp Immunol; 2006 Apr; 144(1):17-24. PubMed ID: 16542360
[TBL] [Abstract][Full Text] [Related]
40. Humoral immunity against the proline-rich peptide epitope of the IgA1 hinge region in IgA nephropathy.
Kokubo T; Hashizume K; Iwase H; Arai K; Tanaka A; Toma K; Hotta K; Kobayashi Y
Nephrol Dial Transplant; 2000 Jan; 15(1):28-33. PubMed ID: 10607764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
